Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Capital Expenditures (2021 - 2025)

Zymeworks' Capital Expenditures history spans 3 years, with the latest figure at -$2.0 million for Q4 2023.

  • For Q4 2023, Capital Expenditures rose 70.84% year-over-year to -$2.0 million; the TTM value through Dec 2023 reached $122000.0, down 87.25%, while the annual FY2023 figure was $122000.0, 87.25% down from the prior year.
  • Capital Expenditures for Q4 2023 was -$2.0 million at Zymeworks, down from $930000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $10.8 million in Q4 2021 and bottomed at -$6.8 million in Q4 2022.
  • The 3-year median for Capital Expenditures is $802000.0 (2023), against an average of $1.3 million.
  • The largest annual shift saw Capital Expenditures crashed 163.64% in 2022 before it surged 125.42% in 2023.
  • A 3-year view of Capital Expenditures shows it stood at $10.8 million in 2021, then tumbled by 163.64% to -$6.8 million in 2022, then skyrocketed by 70.84% to -$2.0 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Capital Expenditures are -$2.0 million (Q4 2023), $930000.0 (Q3 2023), and $802000.0 (Q2 2023).